USANA Health Sciences, Inc.
USNA
$33.06
$0.100.30%
| 09/28/2024 | 06/29/2024 | 03/30/2024 | 12/30/2023 | 09/30/2023 | |
|---|---|---|---|---|---|
| Revenue | 861.97M | 875.12M | 900.45M | 921.01M | 927.89M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 861.97M | 875.12M | 900.45M | 921.01M | 927.89M |
| Cost of Revenue | 164.98M | 168.25M | 171.24M | 176.69M | 180.80M |
| Gross Profit | 697.00M | 706.87M | 729.21M | 744.32M | 747.08M |
| SG&A Expenses | 614.66M | 622.53M | 638.31M | 651.25M | 655.68M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 779.64M | 790.78M | 809.55M | 827.94M | 836.48M |
| Operating Income | 82.33M | 84.34M | 90.90M | 93.07M | 91.40M |
| Income Before Tax | 92.53M | 94.46M | 101.06M | 102.45M | 98.64M |
| Income Tax Expenses | 38.19M | 39.37M | 39.12M | 38.67M | 38.83M |
| Earnings from Continuing Operations | 54.34 | 55.08 | 61.94 | 63.79 | 59.82 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 54.34M | 55.08M | 61.94M | 63.79M | 59.82M |
| EBIT | 82.33M | 84.34M | 90.90M | 93.07M | 91.40M |
| EBITDA | 95.79M | 97.49M | 103.46M | 105.77M | 104.49M |
| EPS Basic | 2.84 | 2.87 | 3.22 | 3.31 | 3.10 |
| Normalized Basic EPS | 3.02 | 3.08 | 3.28 | 3.32 | 3.20 |
| EPS Diluted | 2.83 | 2.86 | 3.21 | 3.30 | 3.09 |
| Normalized Diluted EPS | 3.01 | 3.06 | 3.27 | 3.31 | 3.19 |
| Average Basic Shares Outstanding | 76.58M | 76.75M | 76.99M | 77.10M | 77.11M |
| Average Diluted Shares Outstanding | 76.80M | 77.09M | 77.35M | 77.38M | 77.39M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |
